- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052 ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Creator
-
Smirnov, DV
- Contributor
-
Zhao, G.
Beaurline, JM
Johnson, KE
Capecchi, JT
Harrison, LI
Tomai, MA
Elvecrog, JM
Klinman, DM
Vasilakos, JP
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P138
- URN
-
urn:nbn:de:1111-2016072652299
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Smirnov, DV
- Zhao, G.
- Beaurline, JM
- Johnson, KE
- Capecchi, JT
- Harrison, LI
- Tomai, MA
- Elvecrog, JM
- Klinman, DM
- Vasilakos, JP
- SpringerLink (Online service)
Other Objects (12)
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
3M
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
3m Bleiwalzwerk
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
3M
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
3m Bleiwalzwerk
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
3M
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil